LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Alpelisib | 0.1 | 1.95 | 27.76 | 408 | 225 | 1.8122 | 1.4352 | MN20160318_Q01 | M16 |
MCF 10A-H2B-mCherry | Etoposide | 0.1 | 14.58 | 84.90 | 1189 | 663 | 1.7923 | 1.4348 | MN20160318_Q02 | I13 |
MCF 10A-H2B-mCherry | 0 | 8.76 | 27.76 | 856 | 401 | 2.1339 | 1.4348 | MN20160318_Q01 | F18 | |
MCF 10A-H2B-mCherry | Etoposide | 0.31623 | 14.58 | 84.90 | 1189 | 663 | 1.7923 | 1.4348 | MN20160318_Q02 | M06 |
MCF 10A-H2B-mCherry | 0 | 7.06 | 27.76 | 745 | 360 | 2.0694 | 1.4348 | MN20160318_Q01 | C17 | |
MCF 10A-H2B-mCherry | 0 | 16.29 | 84.90 | 1432 | 766 | 1.8674 | 1.4347 | MN20160318_Q02 | I06 | |
MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 9.47 | 84.90 | 717 | 447 | 1.6025 | 1.4347 | MN20160318_Q02 | E08 |
MCF 10A-H2B-mCherry | Taxol | 0.0056234 | 3.66 | 27.76 | 549 | 283 | 1.9336 | 1.4344 | MN20160318_Q01 | C16 |
MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 12.88 | 84.90 | 893 | 531 | 1.6817 | 1.4344 | MN20160318_Q02 | M18 |
MCF 10A-H2B-mCherry | Alpelisib | 0.0033333 | 14.58 | 84.90 | 1188 | 663 | 1.7908 | 1.4341 | MN20160318_Q02 | J09 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 10.46 | 27.76 | 959 | 438 | 2.1863 | 1.4341 | MN20160318_Q01 | I14 |
MCF 10A-H2B-mCherry | Etoposide | 1 | 7.06 | 27.76 | 744 | 360 | 2.0667 | 1.4339 | MN20160318_Q01 | F03 |
MCF 10A-H2B-mCherry | Vorinostat | 10 | 5.36 | 27.76 | 640 | 320 | 1.9978 | 1.4333 | MN20160318_Q01 | E19 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 12.88 | 84.90 | 892 | 531 | 1.6798 | 1.4333 | MN20160318_Q02 | F07 |
MCF 10A-H2B-mCherry | Vorinostat | 0.56234 | 8.76 | 27.76 | 854 | 401 | 2.1289 | 1.4333 | MN20160318_Q01 | L20 |
MCF 10A-H2B-mCherry | Alpelisib | 0.01 | 12.17 | 27.76 | 1101 | 489 | 2.2512 | 1.4332 | MN20160318_Q01 | J03 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 3.66 | 27.76 | 548 | 283 | 1.9301 | 1.4331 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 7.06 | 27.76 | 743 | 360 | 2.0639 | 1.4330 | MN20160318_Q01 | I13 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 10.46 | 27.76 | 957 | 438 | 2.1817 | 1.4328 | MN20160318_Q01 | L10 |
MCF 10A-H2B-mCherry | Trametinib | 1 | 10.46 | 27.76 | 957 | 438 | 2.1817 | 1.4328 | MN20160318_Q01 | K06 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 5.36 | 27.76 | 639 | 320 | 1.9946 | 1.4323 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Vorinostat | 3.1623 | 7.06 | 27.76 | 742 | 360 | 2.0611 | 1.4322 | MN20160318_Q01 | C15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 3.66 | 27.76 | 547 | 283 | 1.9265 | 1.4318 | MN20160318_Q01 | D14 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 3.66 | 27.76 | 547 | 283 | 1.9265 | 1.4318 | MN20160318_Q01 | G04 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 12.17 | 27.76 | 1098 | 489 | 2.2451 | 1.4316 | MN20160318_Q01 | I15 |